• Kenneth G Linden, Philip M Carpenter, Christine E McLaren, Ronald J Barr, Pamela Hite, Joannie D Sun, Kou-Tung Li, Jaye L Viner, and Frank L Meyskens.
• Department of Dermatology, University of California, Irvine, 101 The City Drive, Orange, CA 92868, USA.
• Recent Results Cancer Res. 2003 Jan 1; 163: 165-71; discussion 264-6.

AbstractNonmelanoma skin cancer is extremely common and is increasing in incidence. It would be very useful to have forms of therapy that would prevent precancerous changes from going on to form cancer, or to reverse the precancerous changes. Epidemiologic evidence in humans, in vitro studies on human cells, and clinical experiments in animals have identified polyphenol compounds found in tea to be possibly useful in reducing the incidence of various cancers, including skin cancer. To examine the potential for a polyphenol from green tea, epigallocatechin gallate, to act as a chemopreventive agent for nonmelanoma skin cancer, a randomized, double-blind, placebo-controlled phase II clinical trial of topical epigallocatechin gallate in the prevention of nonmelanoma skin cancer was performed.

18 keywords...

hide…